Genentech Social Media Collaboration Will Focus On Patient Experiences In Cancer
This article was originally published in The Pink Sheet Daily
Under the five-year research collaboration, Genentech will have broad access to the online patient network PatientsLikeMe, which has 250,000 members.
You may also be interested in...
Research collaboration will give FDA access to individual drug safety reports from patient network’s 350,000 members and could lead to future projects on post-market surveillance.
Global online patient network PatientsLikeMe launches a service to inform clinical trial development with retrospective data mining and prospective research using its online patient network.
Agency favors symptom-focused assessments over global quality-of-life evaluations when considering whether the data can support a drug labeling claim for use in treating pediatric cancer. Measures used for EU reimbursement considerations are usually not sufficient for FDA labeling claims, official cautions.